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Phosphorylation is a reversible post-translational modification that regulates many proteins and enzymes,
including proteases, as shown by two recent publications. Huang and colleagues and Vela´zquez-Delgado
and Hardy (this issue of Structure) describe how phosphorylation activates the protease activity of the
deubiquitinating enzyme DUBA and how it inhibits caspase-6, respectively.Post-translational protein modification
through phosphorylation is central to the
regulation of key cellular processes. The
human ‘‘kinome’’ (Manning et al., 2002;
http://kinase.com/human/kinome/), con-
sisting of at least 518 different kinases,
catalyzes millions of distinct phosphoryla-
tion events. Another well studies post-
translational event is proteolysis, which
is catalyzed by members of the human
‘‘degradome’’ (http://degradome.uniovi.
es/dindex.html). It is well appreciated
that so-called limited proteolysis, where
a specific protease cleaves a specific
substrate at one or several specific
sites, leading to its activation, deactiva-
tion, or subcellular relocation rather than
its complete degradation, is implicated
in many cellular events ranging from
cell division (Dephoure et al., 2008) to
apoptosis (Kurokawa and Kornbluth,
2009). Although the two events are fun-
damentally different—phosphorylation is
a reversible modification, whereas pro-
teolysis is irreversible—there is mounting
evidence that kinases and proteases
work hand-in-hand. For example, the
regulation of both cell proliferation and
apoptosis is dependent on the interplay
between protease and kinases (Lo´pez-Otı´n and Hunter, 2010). Caspase-3-
dependent processing and consequent
inactivation of the serine-threonine pro-
tein kinase AKT1 turns off survival path-
ways, whereas some deubiquitinating
proteases (DUBs) stabilize kinases by
removing ubiquitin tags from proteins
otherwise destined for degradation by
the ubiquitin-proteasome pathway. Like-
wise, phosphorylation is known to acti-
vate or inactivate proteases. Although it
is somehow easier to rationalize how
a proteolytic event leads to the activation
or inactivation of a functional protein, the
structural changes induced by phosphor-
ylation are more subtle. Two recent
papers provide exciting insight into how
phosphorylation can directly regulate
protease activity. While Huang et al.
(2012) provide a structural explanation of
how phosphorylation activates the deubi-
quitinating protease DUBA, Vela´zquez-
Delgado and Hardy (2012; this issue of
Structure) show that introducing a muta-
tion that mimics a biological phosphoryla-
tion event inactivates the apoptotic
protease caspase-6.
The deubiquitinating activity of human
deubiquitinase DUBA is strictly depen-
dent on the phosphorylation of Ser177by the casein kinase II (CK2). Indeed,
the ligand-free, unphosphorylated DUBA
rests in an inactive state, as the substrate
binding site is misaligned and parts of
the molecule appear to be highly mobile.
By itself, CK2 phosphorylation does not
induce any structural changes that would
be consistent with protease activation.
The active conformation is induced only
upon ubiquitin binding, as if the enzyme
‘‘folds around its substrate’’ (Huang
et al., 2012). The phosphate group stabi-
lizes the substrate-protease interaction
but does not directly interact with the
active site residues (Figure 1). It clamps
together two helices and appears in
turn to stabilize the core of the DUBA
structure and is involved in direct interac-
tions with C-terminal part of the ubiquitin
substrate.
Substrate-induced activation has pre-
viously been observed for other, structur-
ally diverse DUBs such as UCH-L3 and
USP7 (Hu et al., 2002; Johnston et al.,
1999). In their ligand free forms, these
enzymes exist in an inactive resting state.
Ubiquitin binding induces the maturation
of the otherwise obstructed and mis-
aligned substrate binding site and cata-
lytic center. This substrate-dependent
Figure 1. Phosphorylation Together with Ubiquitin Aldehyde Binding Is Required to Form
a Mature Active Site in DUBA
In the ligand-free form of DUBA, major parts, including aminoacids 265 to 279, are disordered (yellow
dotted line). Ubiquitin-aldehyde (orange) binding is dependent on phosphorylation of Ser177 and leads
to the restructuring of residues 263–282 and residues 173–188 (red).
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Previewsactivation mechanism might be the basis
for the high specificity of deubiquitinating
proteases; most of the enzymatically
well-characterized DUBs are virtually
inactive on short peptidic substrates
but are highly efficient enzymes when
cleaving ubiquitin based substrates (for
UCH-L3, see Dang et al. [1998]). Phos-
phorylation as described for DUBA acts
as a switch for deubiquitinating activity,
thus adding another level of control.
The structural determinants of how
phosphorylation can directly inhibit a
protease are illustrated by the structure
of the caspase-6 mutant Ser257Asp re-
ported by Vela´zquez-Delgado and Hardy
(2012). This mutation mimics the phos-
phorylation of Ser257, which is catalyzed
by the kinase ARK5. In the structure of
wild-type caspase-6, Ser257 is located
more than 10 A˚ away from the primary
specificity pocket and does not directly
interact with the substrate or the catalytic
center. Steric bulk introduced by phos-
phorylation leads to rearrangement of
loops around the catalytic center and the
substrate recognition groove. These
structural changes have limited impact
on the catalytic residues but inactivate
the enzyme by obilerating the substrate
recognition site.
Although phosphorylation impacts pro-
tease activity of DUBA and caspase-6
in opposite ways, both modificationsappear to regulate protease activity by
impacting substrate recognition rather
than catalysis. In the unphosphorylated
and catalytically inactive state of DUBA,
the catalytic center is in an active confor-
mation and the phosphate group linked
to Ser177 is required to align the sub-
strate binding site and substrate. Like-
wise, phosphorylation of caspase-6 de-
forms the substrate recognition site, but
the catalytic dyad again appears to be in
a catalytically competent conformation.
This observation suggests that alignment
andmisalignment of the substrate binding
site, rather than alteration of the catalytic
residues, is a common strategy for regula-
tion of protease activity. In effect, this is an
analogous mechanism to that of trypsin-
ogen activation. The Ser-His-Asp cata-
lytic triad of trypsinogen, the inactive
form of the digestive protease trypsin,
adopts a conformation almost identical
to that observed in the mature enzyme
(Bode et al., 1978). Upon cleavage of
its propeptide, the novel N-terminus of
trypsin forms a buried, intramolecular
salt bridge, thereby forming the oxyanion
hole (required to stabilize the high-energy
intermediate during catalysis) and rigidify-
ing the highly mobile ‘‘activation domain’’,
including critical sections of substrate-
binding pocket. In contrast to phos-
phorylation though, this is an irreversible
event, and trypsin activity can only beStructure 20, April 4, 2012ablated by endogenous inhibitors. Phos-
phorylation can potentially provide a
much more nuanced strategy for modula-
tion of signaling pathways where prote-
ases, kinases, and phosphatases play
a critical role.
Furthermore, the structures of cas-
pase-6 and DUBA also underscore the
inherent plasticity of these enzymes.
More and more structures indicate that
proteases adopt multiple conformations
and do not simply rest as an inactive
zymogen that is then transformed directly
into the active form during maturation.
More precisely, maturation is a multistep
process that includes spatial and/or
temporal regulation, post-translational
modification, and substrate-induced con-
formational modification and allows for
fine tuning of the proteolytic signal. Using
small molecules or biologics to trap these
enzymes in an active or inactive state
could also allow for more precise control
of dysregulated biological processes
and is an attractive avenue for the devel-
opment of pharmacological intervention
(Lee and Craik, 2009).
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